stuttering epidemiology forecast

DelveInsight’s ‘Stuttering – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of stuttering, historical and forecasted epidemiology, as well as the trends in the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan. 

Stuttering Understanding

Stuttering also known as childhood-onset fluency disorder or stammering, is a multifactorial speech disorder that disrupts the rhythm and flow of how the person talks, causing unintended sounds, pauses, or other problems with talking smoothly. Stutterers commonly exhibit repetitions and prolongations as primary symptoms of their speech disorder. These primary symptoms involve repeating sounds or syllables and stretching out sounds for an extended period. In addition to these primary symptoms, stutterers may also experience secondary symptoms such as avoidance behaviors and frustration. 

Researchers believe that stuttering is caused by a combination of factors, including genetics, language development, environment, as well as brain structure and function. The exact cause of stuttering is still unknown, but it is widely agreed upon that it is a complex neurodevelopmental disorder. Stuttering most often begins between the ages of two and four when children's speech and language abilities are rapidly expanding. Furthermore, it is classified into three types: neurogenic stuttering, psychogenic stuttering, and developmental stuttering. Neurogenic stuttering is associated with a flaw in the makeup of the brain, psychogenic stuttering is linked to a profound psychological challenge or trauma while developmental stuttering typically starts in early childhood. 

Geographies Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Stuttering Diagnosis 

A speech-language pathologist diagnoses stuttering by evaluating the child's speech and language abilities. Furthermore, they may use various assessment tools, such as the SSI-4, TOCS, OASES-A, OASES-T, and OASES-S, to evaluate the child's speech and language abilities. These instruments help to assess the severity and type of stuttering, which is essential for developing an appropriate treatment plan. 

Continued in the report…..

Stuttering Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of stuttering, diagnosed prevalent cases of stuttering, and gender-specific diagnosed prevalent cases of stuttering in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2021 to 2034.

Stuttering Detailed Epidemiology Segmentation

• According to estimations by DelveInsight, the total prevalent cases of stuttering across the 7MM stood at roughly 4,013,792, with nearly 885,952 diagnosed prevalent cases reported in 2023. It is anticipated that these cases will increase by 2034, attributable to enhanced comprehension of the condition and increased awareness among healthcare practitioners and the general public at large.
• Among the 7MM, the US accounted for approximately 47%, EU4 and the UK for nearly 38%, and Japan for around 15% of the total diagnosed prevalent cases of stuttering in 2023; these cases are expected to increase by 2034 due to improved diagnostic methods, leading to more accurate identification and reporting of stuttering cases globally. 
• Among EU4 and the UK, in 2023 Germany accounted for the highest diagnosed prevalent cases of stuttering, with nearly 88,271 cases, followed by the UK with approximately 68,060 cases. On the other hand, Spain had the lowest diagnosed prevalent population with nearly 49,392 cases in 2023. These cases are expected to change during the forecast period (2024-2034).
• As per DelveInsight’s analysis, in 2023, a gender-specific distribution of the disease suggests male predominance with approximately 664,464, cases while females were at a lower count with nearly 221,488 cases of the total diagnosed prevalent cases in the 7MM. These cases are expected to increase during the forecast period due to societal and cultural influences on reporting and diagnosis, potentially resulting in males experiencing less stigma or societal pressure to conceal their speech difficulties in comparison to females.
• Japan accounted for nearly 131,892 diagnosed prevalent cases of stuttering in 2023, out of which nearly 75% of cases were of males and 25% of cases were of females in 2023. These cases are expected to increase during the forecast period due to changing cultural that norms may encourage individuals to seek help for their speech difficulties, contributing to an increase in diagnosed cases of stuttering.

Stay ahead with in-depth analysis of the Stuttering Market Forecast-discover emerging therapies, epidemiology data and growth opportunities.

Scope of the Report

• The report covers a descriptive overview of stuttering, explaining its symptoms, pathophysiology, and various diagnostic approaches.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 (Germany, France, Italy, and Spain) the United Kingdom, and Japan.
• The report assesses the disease risk and burden of stuttering.
• The report helps recognize the growth opportunities in the 7MM concerning the patient population.
• The report provides the segmentation of the disease epidemiology for the 7MM, by total prevalent cases of stuttering, diagnosed prevalent cases of stuttering, and gender-specific diagnosed prevalent cases of stuttering.

Report Highlights

• 11 years forecast of stuttering
• The 7MM Coverage
• Total prevalent cases of stuttering
• Diagnosed prevalent cases of stuttering
• Gender-specific diagnosed prevalent cases of stuttering

Key Questions Answered

• What are the disease risks and burdens of stuttering?
• What is the historical stuttering patient pool in the United States, EU4 (Germany, France, Italy, and Spain) the United Kingdom, and Japan?
• What would be the forecasted patient pool of stuttering at the 7MM level?
• What growth opportunities will be across the 7MM concerning the patient population with stuttering?
• Which country would have the highest diagnosed prevalent population of stuttering among the countries mentioned above during the forecast period (2023–2034)?
• At what CAGR is the population expected to grow across the 7MM forecast period (2023–2034)?

Reasons to Buy

The stuttering report will allow the user to:

• Develop business strategies by understanding the trends shaping and driving the 7MM stuttering epidemiology forecast.
• The stuttering epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The stuttering epidemiology model developed by DelveInsight is easy to navigate, interactive with a dashboard, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of Disease by Segmentation 
• Factors Driving Growth in a Specific Patient Population